NavaDerm Partners, a Northeast-based regional dermatology platform and portfolio company of BelHealth Investments Partners LLC, has named Alejandro Fernandez as CEO. Also, NavaDerm has appointed Edward Conway as chief financial officer and Kimberly Campbell as executive vice president of business development and recruiting.
New York, New York – July 20, 2018 – NavaDerm Partners, LLC (“NavaDerm” or the “Company”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, announced the appointment of NavaDerm’s executive management team.
NavaDerm named Alejandro Fernandez as Chief Executive Officer. Mr. Fernandez has over 25 years of experience leading multi-site physician practice operations. Mr. Fernandez was most recently the Chief Executive Officer for Gastro Health, a practice management company that specializes in owning and operating gastroenterology practices and ambulatory surgical centers. In this role, Mr. Fernandez oversaw a number of acquisitions, de novo practice formations, and additions of ancillary services including ambulatory surgery centers, anesthesia, pathology laboratories, imaging, manometry, infusion, and specialty pharmacy.
The Company is pleased to announce the appointment of Edward Conway as Chief Financial Officer. Mr. Conway is an experienced accounting and financial executive who has held senior leadership roles across multiple industries over the last 15 years. Most recently Mr. Conway served as Director of Finance at Envision Physician Services (NYSE: EVHC), a leading physician practice management company, where he was responsible for the finance functions of the Northeast and Mid-Atlantic regions. Mr. Conway began his career at Arthur Andersen and KPMG.
Finally, the Company appointed its founding partner, Kimberly Campbell, as Executive Vice President of Business Development and Recruiting. Ms. Campbell is a highly experienced dermatology executive with over 20 years’ experience in the sector. Most recently, she served as Founder and CEO of Dermatology Authority, an executive recruitment and consulting company focused on Dermatology. Ms. Campbell was previously Director of Professional Relations for Dermpath Diagnostics a division of Quest Diagnostics, the world’s largest dermatopathology laboratory. Her responsibilities included business development, marketing, and sales management.
Alejandro Fernandez, CEO of NavaDerm, stated “I am thrilled to join NavaDerm as its CEO. In partnering with six terrific founder physicians and a financial sponsor that understands how to scale healthcare service companies, we have an exceptional foundation from which to build the region’s #1 dermatology platform.
NavaDerm will remain focused on high quality patient care, strong clinical outcomes and supporting all of our dermatologist partners. In order to accelerate growth, we look forward to hiring additional physicians, opening de novo practices and pursuing strategic acquisitions.”
Paul Barrett, Managing Director of BelHealth, said, “We are excited to partner with our terrific executive management team and build the region’s top dermatology platform. With Alejandro as CEO, we have a leader that built one of the country’s top GI platforms and understands what it takes to build a physician practice management business from the ground up into one of the country’s leaders. In leveraging Kim’s extensive experience and network in dermatology and Ed’s financial acumen in healthcare services, our team has complementary experience and the base from which to build an exceptional organization.”
About NavaDerm Partners
NavaDerm Partners is a Northeast-based dermatology platform formed through the recapitalization of four dermatology groups in New York and New Jersey. The consolidated platform consists of 19 dermatologists and 2 physician assistants providing comprehensive general dermatology across medical, surgical and cosmetic procedures. The consolidated group had over 100,000 patient visits in the most recent year.
About BelHealth Investment Partners
BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth has a unique combination of investing, executive management and entrepreneurial experience. BelHealth acquires majority positions in entrepreneur-owned companies that it believes would benefit from its extensive operating and private equity investment expertise. The firm invests across three core healthcare segments: Services, Products and Distribution. BelHealth is investing from its current $350 million fund.